chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Inflamed lymph nodes under the left armpit; The initial case was missing the following minimum criteria: (unspecified product) Upon receipt of follow up information on (20Oct2022), this case now contains all required information to be considered valid.  This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENITIS (non-serious), outcome "unknown", described as "Inflamed lymph nodes under the left armpit".  Additional Information: On 20Oct2022, reporter reported that we were working together at a local food and she shared this information with me. I reported it in immediately after she informed me so the awareness date and reported date are the same. The medicine was Comirnaty. Any other questions please let me know.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fatigue  Headache  Joint pain-stopped after 24 hours or so Muscle pain stopped after 36 hours or so Hypersomnia Night sweats 2 nights
Child received seasonal flu shot. She felt dizzy after receiving shots. BP 108/80. HR 66. Five minutes later c/o headache. VS remained stable. Sent to health room with no dizziness, c/o mild headache.
Information has been received from a physician concerning an 18 year old female who on unspecified date was vaccinated with a first dose of GARDASIL. On 17-JUL-2008 the patient was vaccinated intramuscularly in the right shoulder with a second dose of GARDASIL. Concomitant therapy included MENACTRA which was vaccinated intramuscularly in the left shoulder and ADACEL at the same visit on 17-JUL-2008 at different injection sites. On approximately 20-JUL-2008 the patient experienced generalized rash all over her body. The patient spoke to the physician about the rash. At the time of reporting the patient's generalized rash all over her body persisted. No further information is available.
expired Covid vaccine administered to 3 employees.     Event details:  o         Vial opened on Wed 2/16 at 3pm; Vial was dated/labelled. Evening nurse was to take the booster, then discard. At the end of shift she refused booster, but vial wasn?t discarded/waisted.  o         Opened vial was refrigerated, dated/initialed.  o         CN/CM were at another clinic due to bad weather. A nurse from another clinic offered to help with vaccinations and gave a booster dose was given to 3 employees from opened vial.  o         Vaccines given Friday 2/18 at 3pm to 3 employees.  o         CM/CN noted there was still one unopened vial left in refrigerator on Monday.
I received my second COVID-19 booster, which was from Pfizer, on 6/8/2022 at around 11 AM. At about 6 PM on the same day, I was at a public gathering. I was feeling really hot; while other people were putting on sweaters, I was taking mine off. When we left the gathering at about 9 PM, I was freezing. I took my temperature, and it was 100.4. I then went to bed. When I woke up at around 8:30 AM on 6/9/2022, my temperature was 101.2. I took a Tylenol or Advil and then went back to sleep. I had no appetite, so I didn't eat anything. At around 2 PM that day, my temperature was around 100.3. I then went back to sleep. At 5:30 PM the same day, the temperature was 101.8. At this point, I was also having chest pains. I was alarmed by the chest pains, but they then went away. I then went back to sleep. On 6/10/2022, my temperature was 97.5 at 7:20 AM. Even though my fever had broke, I still felt bad and had a cough. I had chest pains that day 9:57AM-10:07AM, 10:25AM-10:34AM, and 6:13PM-6:21PM. When I took my temperature at 10:40AM, it was 98.3. At 3 PM, the temperature was 99.1. At 4:45 PM, it was 99.3. Again, I spent much of the day sleeping. At the time of this writing, I don't really remember if I took any medicines to treat the symptoms, but if I did, they were OTC. On 6/11/2022, the temperature was 97.9 at 5:30 AM. At 8:45 AM, it was 98.5. At 12:30PM, it was 99.0. At 2:30 PM, it was 98.7. I don't remember much about that period, but I likely spent most of the day in bed. During the entire time, I had a persistent cough. On 6/12/2022, my temperature was below 98 for the entire day. I had a headache, but I went outside once, and I felt weak. At this point, I still didn't have much of an appetite. On 6/13/2022, I was pretty much back to my normal self. I previously had COVID-19 in December 2020. Before I had it, I had had a persistent cough, which diminished just before I got COVID-19. After I got COVID-19, though, it returned and has persisted ever since. I have seen pulmonologists, gastroenterologists, ENTs, and allergists ever since in a quest to find the source of the cough. My gastroenterologist prescribed me omeprazole in May 2022, and this really helped the cough, which may have been caused by irritation caused by acid in the esophagus. The difference was so noticeable that other people even remarked on it.
Swelling following day after immunization and lesions 2 days after immunization. Site of the injection is itchy.
Patient got a PNEUMOVAX shot she didn't need and thinks it caused swelling and redness. She iced it and it went down and is ok after 3 days.
56 adults patients received doses after its expiration date Jul 13, 2022; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 004m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022).    This case was created for 5th patient out of 56 patients. Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Doses were administered after 30-day Use By Date or after manufacturer date of expiry. It was unknown to HCP when the vials were stored in the refrigerator and when the doses were administered. The vial had not underwent temperature excursion. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-701125 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-701125:Master case
Fever, Nausea Vomiting, injection site pain Narrative: Missed one day of work due to symptoms following 2nd dose of vaccine
Information has been received from a registered nurse referring to a 6 month old patient of unknown gender. On 23-JUN-2015 the patient was vaccinated with oral, ROTATEQ (oral, lot # K017573, expiration date and dose were unknown) which excursed the storage temperature (incorrect product storage). No reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient experienced chest pain 3 days after vaccination. Was admitted to hospital and underwent cardiac catheterization. Diagnosis of myocarditis was given and patient was started on beta-blocker, ace-inhibitor and short course of colchicine.
On 2/3 area from injection site to elbow became erythematous, pruritic, and edematous. Symptoms continued through today (2/5/2021).
Patient developed hardness, swelling, redness at the deltoid injection site, and the redness traveled down to the armpit over then next several hours.
No additional AE/PQC; MMRII with a labeled expiry of 5/29/2022 was administered; This spontaneous report has been received from an office manager via company representative concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 27-JUN-2022, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) 0.5 milliliter (lot# T018669, has been verified to be a valid lot number for measles, mumps, and rubella [wistar ra 27-3] virus vaccine, live [rHA] [M-M-R II], expiration date reported and upon internal validation established as 29-MAY-2022) for prophylaxis (Expired product administered).  No adverse event was reported.; Sender's Comments:  US-009507513-2207USA007049: US-009507513-2207USA007043:
This spontaneous report as received from a pharmacist via field representative regarding a patient of unknown age with beef allergy. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot number, expiry date, dose and route were not reported). No concomitant medications were reported. The pharmacist was reported that the patient was experienced an unspecified reaction after administration of ZOSTAVAX. The patient was sought the medical attention but type was unknown. On an unspecified date, the patient recovered from the event. The causality for the event with the ZOSTAVAX was unknown. Additional information has been requested.
arm r a little sore; had a fever; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and fever. On an unknown date, the outcome of the pain in arm and fever were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported.  The patient took the 2nd shot for shingles in right arm, little sore and had a fever. The patient asked how long should it last.
No adverse symptoms reported by the patient who was vaccinated. However, we noticed after the patient was vaccinated, the vaccine dose used was expired. It was drawn up on Friday, 12/10/2021 at 10:20 am. It expired 4:20 pm on Friday, 12/10/21. However, it was not disposed of on Friday and therefore used today on this patient. We called the Pfizer manufacturer and they recommended we administer another dose to this patient as the one administered today 12/13/2021 at 11:02 am was considered an invalid dose. Pfizer safety team report #Q9NG1ZEW and case #00510937.
pt exp fever, OM, arms shook, clench tight, twitch, shake or jerk; convuls, weak, shook, fists were tight & body would twitch & jerk;
I have tinnitus and mild ear pain in my right ear.  My doctor examined my ears and did not see any ear wax or inflammation.  I got very sick in late February 2020 with COVID-like symptoms (severe headache, fever of 104, fatigue, loss of taste, and a dry cough).  Approximately 3 days into being sick I developed a significant pain in my right ear.  It took me approximately 6 to 7 days to recover and the ear pain subsided.  The dry cough lasted another two weeks or so.  I went to the ER because my headache was so intense and my fever was so high.  They gave me a flu test but that came back negative.  They were not able to diagnose what I had.  The tinnitus  and ear pain started approximately 1 week after my first Moderna dose and has lasted now for about 6 weeks.  My doctor prescribed prednisone but that is not working.
Patient came in to get second pfizer covid vaccine and stated that after his first vaccine he had a pain down his arm into his hand. He stated that he did not think much of it until a few day later when his hand was still bothering his and having trouble closing his pinky finger while making a fist. He stated that now it feels more like joint pain in his knuckles. He stated that he does not have a doctor to talk to about this and we talked about how it may be "covid arm" which can happen and does go away for most people but can last a while. I stated that it was completely up to him if he wanted to get the second vaccine or if he wanted to wait and the patient decided to get the second vaccine today in the opposite arm. He waited the 15 minutes after and did not have any problems with the second vaccine
I had my period last week. The day after my vaccine, my vagina kept bleeding on and off. The consistency of the blood was much thinner than what I generally experience during my period. On the second day after, I am currently experiencing occasional pain in my genital area. This is embarrassing for me to write but I know others who have experienced similar side effects. For this reason, I feel the need to voice this side effect.
Approximately 7 days after she received her first dose of the Moderna COVID vaccine, she developed diffuse urticarial as well as purpuric rash involving most of her body, swelling of her joints, lips, extremities, and face lasting several weeks.
It itched a little; tender to touch; weakness in my hands; as the day progress it gets worse; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (It itched a little), TENDERNESS (tender to touch), DIZZINESS (dizzy), MUSCULAR WEAKNESS (weakness in my hands) and CONDITION AGGRAVATED (as the day progress it gets worse) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (dizzy). On an unknown date, the patient experienced PRURITUS (It itched a little), TENDERNESS (tender to touch), MUSCULAR WEAKNESS (weakness in my hands) and CONDITION AGGRAVATED (as the day progress it gets worse). At the time of the report, PRURITUS (It itched a little), TENDERNESS (tender to touch), DIZZINESS (dizzy), MUSCULAR WEAKNESS (weakness in my hands) and CONDITION AGGRAVATED (as the day progress it gets worse) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Patient fainted after blood draw at the lab in clinic. Per lab techs patients started to "go out" after completion of blood draw and was helped down to the floor by lab techs. Per lab techs patients eyes fluttered for a few secs and then patient came around. No tonic clonic seizure or convulsions. No history of seizures. Patient had received HPV immu. approx 30-40 min ago. Patient advised to rest and go to ER if any problems.
Woke up in middle of the night with 101 degree temp, nausea, tingling skin. That morning skin still felt weird. No reaction at site. TYLENOL did help.
patient sure did get the flu; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 07-Dec-2020.  This case involved unknown demographic patient who sure did get the flu (influenza) while received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect Influenza Vaccine (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, unspecified time after receiving the vaccine, it was reported that patient sure did get the flu(influenza). Patient was home sick.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.  The reporter assessed the causal relationship with suspect vaccine as related.
cardiac tamponade, pericarditis, elevated pulse, pneumonia, aspiration. Began March 27th, has been hospitalized since then, discharged 3 times but never home more than 1 week
Student said this morning that he is experiencing a "pins and needles" type of feeling everywhere his clothing touches after receiving his vaccine yesterday morning at a school vaccine clinic. Further evaluation is ongoing
Patient called today and told me that he experienced some numbness on the left side of his face approximately 15 minutes after receiving his vaccine.  He stated that he thought he was just having a hysterical reaction and overthinking it.  The numbness continued and he went to the emergency room  later that same day.  He was seen by an ER physician and told that he was experiencing temporary Bell's Palsy from the vaccine.  He described the numbness as being below his eye, in front of his ear and halfway down his jaw.  He said it lasted approximately 36 hours and then it was gone.
pt recvd vax on 28JUN93 devel maculoapapular mild erythematous rash on 7JUL-AUG93 pos pruritus;
Patient states she started having side effects from the vaccine starting on Saturday 7/10/21. This is two days after her vaccine was given. She states she suffered a small seizure and nausea/vomiting. She states the nausea/vomiting has continued and has not resolved going into today, 7/14/21. This is the first time she has called to report this to us. She was advised to go into an urgent care or ED as soon as possible for evaluation due to the seizure and continual vomiting. I advised her to stay hydrated with an electrolyte containing drink such as Pedialyte or Gatorade. I mentioned she could use an over the counter nausea medication in the meantime as well. Unknown at this point if patient went in for an evaluation.
pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2022-531858, MOD-2022-531860, MOD-2022-531856.
Approximately 2 weeks after his first immunization, (early February 2019) he developed an "itchy rash" across his abdomen and some on his lower back. He reports that "rash and itching" went away "about 2 weeks ago" (early April 2019). Denies ever having pain with the rash.
Narrative:  COVID infection following COVID vaccine series 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: exposure: unknown
Dizzy, nausea, diarrhea, projectile vomiting, fever.
Hives on the injection site; tightness in the chest; Hives on the face, torso and collar bone; chills; Did not feel well; tingling; Itchiness on the face; A spontaneous report was received from a consumer concerning 60 years old female  patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tingling on limps and scalp, itchiness on face, did not feel well,chills,tightness in chest, hives on face, torso and collar bone and hives on injection site.  The patient's medical history was reported as current condition of hypersensitivity and historical condition of autoimmune disorder.  Concomitant medications were reported as hydrochlorothiazide, ramipril and xelijanz.  On 21 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 032L20A) via unknown route in left arm for prophylaxis of COVID-19 infection.  On 22 Feb 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch number: 024M20A) via unknown route in left arm for prophylaxis of COVID-19 infection.  On 22 Feb 2021, the patient experienced itchiness on face, tingling on limps and scalp.  On 23 Feb 2021, the patient experienced chills and feel not well.  On 24 Feb 2021, the patient experienced hives on face and torso, itchy and tightness in chest.  On 25 Feb 2021, the patient experienced hives on injection site, collar bone and face, and itchy everywhere.  Treatment details were reported as the patient took methylprednisolone, half a benadryl and the inhaler to treat symptoms.  All the event occurred after the second dose of COVID vaccination.  The outcomes of all the event remain unknown.  Action taken with mRNA-1273 in response to the events are unknown; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027833:Same patient, 1st dose
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-AUG-2008, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 04-JAN-2009, the patient was treated by a licensed practical nurse for a vesicular outbreak accompanied by weakened immune symptoms, which was diagnosed as herpes zoster. The patient was prescribed acyclovir for management of her painful symptoms and chronic pain. On or about 19-JAN-2009, the patient sought subsequent treatment from a licensed practical nurse for neuropathic pain secondary to zoster infections. The patient was prescribed LIDODERM to ease her painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
HEMODIALYSIS PT TESTED NEG FOR HBSAG PRIOR TO 1ST DOSE OF ENGERIX-B GIVEN ON 2/28/90.RESULTS FOR HBSAG ON 3/7/90 "WEAKLY POS" PT RECEIVED 2ND DOSE ENGERIX-B ON 3/31/90 AND TESTED POS FOR HBSAG.SUBSEQUENT TESTS ON 4/4,9 AND 10/90 ALL NEG.
Asthma flair up, abdominal pain, blood clot, headache, and lack of sleep.
Patient was drowsy, unresponsive but breathing, O2 sat 97-98% on r/a. Drooling. BP dropped from 140.86 to 90/60. Skin felt clammy. After about 10 mins-15 mins paramedics arrived. Patient was responsive and talking. BP went back up. Patient escorted to ER w/paramedics.